Wernicke's encephalopathy in Crohn's disease and ulcerative colitis.
Clinical nutrition
Crohn's disease
Dietary
Gastrointestinal
Inflammation
Thiamine
Ulcerative colitis
Wernicke's encephalopathy
Journal
Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
21
03
2020
revised:
31
12
2020
accepted:
19
01
2021
pubmed:
22
2
2021
medline:
24
6
2021
entrez:
21
2
2021
Statut:
ppublish
Résumé
Crohn's disease (CD) and ulcerative colitis (UC) are chronic and debilitating inflammatory conditions of the gastrointestinal tract. Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder. Our objective was to systematically review the presentation of WE in CD and UC. We conducted our search from inception using the MeSH terms "Crohn's disease," "ulcerative colitis," and "Wernicke's encephalopathy." Our search yielded 28 case studies reporting on 31 cases. CD was diagnosed in 21 cases, and UC in 10. The first signs of WE were nausea and vomiting (13 cases), double vision (10), blurred vision (10), and hearing loss (4). In 12 cases, partial or complete bowel resection was one of the etiologies of thiamine depletion. In nine cases, thiamine was not supplemented intramuscularly or intravenously while parenteral nutrition or glucose was given to the patient. In 10 cases, detailed descriptions of thiamine treatment were given. Thiamine treatment at suboptimal levels (7 of 10 cases) turned out to lead to residual cognitive deficits in three cases. In three cases with optimal treatment (1500 mg/d intravenously), complete remission of WE symptoms was achieved. Rapid treatment with high doses (500 mg, 3 times/d) of thiamine saves lives, and treats WE in its core symptomatology.
Identifiants
pubmed: 33611107
pii: S0899-9007(21)00044-7
doi: 10.1016/j.nut.2021.111182
pii:
doi:
Substances chimiques
Thiamine
X66NSO3N35
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
111182Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.